NICE’s approach to measuring value

BMJ

5 January 2021 - Appleby asks whether COVID-19 vaccines would be considered cost effective using the NICE approach to measuring value—and questions whether NICE’s methods are appropriate.

The pandemic has highlighted fundamental questions about what we choose to value in society, including how to balance health impacts with wider societal and economic effects.

Read Letter to the Editor of the BMJ

Michael Wonder

Posted by:

Michael Wonder